We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Three-month interim data showed hyaluronic acid dermal ...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (EOLS) (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced positive ...
The US FDA has expanded the arsenal of aesthetic dermatology treatments with another approved indication for a hyaluronic acid dermal filler and clearance for a device that removes “micro-cores” of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback